Cargando…
Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study
The prognosis of metastatic lung adenocarcinoma (MLUAD) varies greatly. At present, no studies have constructed a satisfactory prognostic model for MLUAD. We identified 44,878 patients with MLUAD. The patients were randomized into the training and validation cohorts. Cox regression models were perfo...
Autores principales: | Wu, Bo, Chen, Jianhui, Zhang, Xiang, Feng, Nan, Xiang, Zhongtian, Wei, Yiping, Xie, Junping, Zhang, Wenxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750683/ https://www.ncbi.nlm.nih.gov/pubmed/36626448 http://dx.doi.org/10.1097/MD.0000000000032217 |
Ejemplares similares
-
Lymph node ratio predicts overall survival in patients with stage II non-small cell lung cancer: a population-based SEER analysis
por: Feng, Nan, et al.
Publicado: (2022) -
The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
por: Tie, Xiaowei, et al.
Publicado: (2022) -
Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature
por: Guo, Qiang, et al.
Publicado: (2023) -
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
por: Li, Binfeng, et al.
Publicado: (2020) -
Prognostic impact of metastatic patterns and treatment modalities on overall survival in lung squamous cell carcinoma: A population-based study
por: Qin, Lang, et al.
Publicado: (2023)